Source link : https://www.newshealth.biz/health-news/batoclimab-shows-rapid-effect-on-key-graves-disease-markers/
CHICAGO — The investigational monoclonal antibody batoclimab showed safety and rapid and significant improvement in key markers of Graves’ disease, with some patients who failed to improve with standard antithyroid drugs (ATDs) showing a normalization or near-normalization of markers within just weeks of batoclimab initiation. “These data are the first clinical evidence that neonatal fragment […]
Author : News Health
Publish date : 2024-11-04 12:20:22
Copyright for syndicated content belongs to the linked Source.
Categories